Name and surname:
|
doc. MUDr. Zuzana Čierna, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Assistant professor (2010-2019), associate professor (2019 - ) | Department of Pathology, Faculty of Medicine, Comenius University and University hospital Bratislava | 2010 up to now |
Assistant professor (2018 - ) | Department of Pathology, Faculty of Health Care and Social Work, Trnava University and Faculty hospital Trnava | 2018 up to now |
Scientific-research activity | Medirex Group Academy | 2014 - 2021 |
Medical doctor | St. Elisabeth Cancer Institute Bratislava | 2012 - 2014 |
Postgraduate student | Department of Gynaecology and Obstetrics, Faculty of Medicine, Comenius University and Faculty Hospital, Bratislava | 2002 - 2010 |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
Specialization in Pathological anatomy | Faculty of Medicine, Comenius University | 2017 |
Specialization in Healthcare Management and Financing | Faculty of Medicine, Comenius University | 2021 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Pathological anatomy 1 + 2 in slovak and english language | General medicine | I.+II. | General medicine |
Pathological anatomy 1 + 2 in slovak and english language | Dentistry | I.+II. | Dentistry |
V.5.a - Name of the course | V.5.b - Study programme | V.5.c - Degree | V.5.d - Field of study |
---|---|---|---|
Surgical pathology | General medicine | I.+II. | General medicine |
Cierna, Z., Mego, M., Miskovska, V., Machalekova, K., Chovanec, M., Svetlovska, D., Hainova, K., Rejlekova, K., Macak, D., Spanik, S., Ondrus, D., Kajo, K., Mardiak, J., Babal, P. 2016. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors. In: Ann Oncol. 2016, 27(2). 300-305. (IF = 11,855; Q1)
Chovanec, M., Cierna, Z., Miskovska, V., Machalekova, K., Kalavska, K., Rejlekova, K., Svetlovska, D., Macak, D., Spanik, S., Kajo, K., Babal, P., De Giorgi, U., Mego, M., Mardiak, J. 2018. Systemic immune-inflammation index in germ-cell tumours. In: Br J Cancer. 2018, 118(6). 831-838. (IF = 5,416; Q1)
Chovanec, M., Cierna, Z., Miskovska, V., Machalekova, K., Svetlovska, D., Kalavska, K., Rejlekova, K., Spanik, S., Kajo, K., Babal, P., Mardiak, J., Mego, M. 2017. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors. In: Oncotarget. 2017, 8(13). 21794-21805. (Q1/Q2)
Cierna, Z., Mego, M., Janega, P., Karaba, M., Minarik, G., Benca, J., Sedlackova, T., Cingelova, S., Gronesova, P., Manasova, D., Pindak, D., Sufliarsky, J., Danihel, L., Reuben, J. M., Mardiak, J. 2014. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. In: BMC Cancer. 2014, 14(1). 472. (IF = 3,362; Q2)
Mego, M., Cierna, Z., Svetlovska, D., Macak, D., Machalekova, K., Miskovska, V., Chovanec, M., Usakova, V., Obertova, J., Babal, P., Mardiak, J. 2013. PARP expression in germ cell tumours. In: J Clin Pathol. 2013, 66(7). 607-612. (IF = 2,551; Q2)
Cierna, Z., Miskovska, V.,Roska, J., Jurkovicova, D., Pulzova, LB., Sestakova, Z., Hurbanova, L., Machalekova, K., Chovanec, M., Rejlekova, K., Svetlovska, D., Kalavska, K., Kajo, K., Babal, P., Mardiak, J., Ward, TA., Mego, M., Chovanec, M. 2020. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours. In: BMC Cancer. 2020, 20(1). (IF = 4,430, Q2)
Schmidtova, S., Kalavska, K., Gercakova, K., Cierna, Z., Miklikova, S., Smolkova, B., Buocikova, V., Miskovska, V., Durinikova, E., Burikova, M., Chovanec, M., Matuskova, M., Mego, M., Kucerova, L. 2019. Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells. In: Cancers. 2019, 11(9). (IF = 6,126; Q1)
Cierna, Z., Smolkova, B., Cholujova, D., Gronesova, P., Miklikova, S., Cihova, M., Plava, J., Mego, M. 2021. Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients. In: Sci Rep. 2021; 11(1). (IF = 4,996; Q2)
Smolkova, B., Cierna, Z., Kalavska, K., Miklikova, S., Plava, J., Minarik, G., Sedlackova, T., Cholujova, D., Gronesova, P., Cihova, M., Majerova, K., Karaba, M., Benca, J., Pindak, D., Mardiak, J., Mego, M. 2021. Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients. In: IJMS. 2021; 21(24). (IF = 5,6; Q1)
Kalavska, K., Cierna, Z., Karaba, M., Minarik, G., Benca, J., Sedlackova, T., Kolekova, D., Martonova, I., Mardiak, J., Mego, M., Pindak, D. 2021. Prognostic role of matrix metalloproteinase 9 in early breast cancer. In: Oncology Letters. 2021; 78. (IF = 2,9; Q2)
Genomic landscape of platinum resistant and sensitive testicular cancers. Macintyre, G.; Brenton, J.D.; O'Connor, S.
The developmental origin of cancers defines basic principles of cisplatin resistance. Murray, M.J.; Coleman, N.
Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours. Taylor, J.C.; Alveyn, E.; Verrill, C.
Personalized medicine: Stem cells in colorectal cancer treatment. Patsalias, A.
Clinical Response of a Patient to Anti-PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors. Ward, J.E.; Bao, R.; Hall, C.R.; Brockstein, B.E.; Luke, J.J.; Shah, S.
Identification of new treatment options in refractory testicular germ cell tumors.